| | Presentation | Media | Date |
| AlzeCure medverkar på Erik Penser Banks temadag Life Science december 2, 2021 (Swedish)
|
|
|
December 2, 2021
|
| Follow us – Stay updated
| |
|
November 22, 2021
|
| AlzeCure Pharma – Redeye Life Science Day
| |
|
November 11, 2021
|
| AlzeCure update on the latest developments – Interview with CEO Martin Jönsson about the company, its projects developments in Alzheimer’s and pain, and future plans.
| |
|
October 22, 2021
|
| Alzecure presents at Healthcare Innovation Summit
|
|
|
October 7, 2021
|
| Characterization of positive allosteric modulators of TrkB for the treatment of depression
|
| |
October 2, 2021
|
| Alzecure Pharma – Naventus Life Science Summit
|
|
|
September 29, 2021
|
| Aktiespararna interview CEO Martin Jönsson – latest quarterly report and future prospects. (Swedish)
| |
|
September 20, 2021
|
| AlzeCure Pharma – Aktiedagen Stockholm. (Swedish)
| |
|
September 7, 2021
|
| Development plan for NeuroRestore ACD856 by Dr Johan Sandin, PhD Chief Scientific Officer
|
|
|
September 1, 2021
|
| NeuroRestore Background and evolution by Dr Pontus Forsell, PhD Head of Discovery & Research
|
|
|
September 1, 2021
|
| Company Overview & Vision by Martin Jönsson CEO
|
|
|
September 1, 2021
|
| Alzheimer’s disease and the neurotrophins BDNF/NGF by Prof. Maria Eriksdotter M.D., PhD
|
|
|
September 1, 2021
|
| Strategy Update on Alzheimer’s Disease & NeuroRestore
|
|
|
September 1, 2021
|
| ACD856 – a novel positive allosteric modulator of Trk-receptors in clinical development for the treatment of Alzheimer’s disease; Scientific presentation at AAIC, July 26-30, 2021
|
|
|
July 29, 2021
|
| About AlzeCure’s origin and development – An embryo that can be something big – with Bengt Winblad, professor, senior at Karolinska Institutet. (Swedish)
| |
|
June 11, 2021
|
| Negative Allosteric Modulators of TrkA for the Treatment of Pain – Scientific presentation at the IASP conference on pain, June 2021
|
|
|
June 11, 2021
|
| About suffering from Alzheimer’s disease, diagnostics, care today and future needs – with Bengt Winblad, professor, senior at Karolinska Institutet. (Swedish)
| |
|
June 11, 2021
|
| About Alzstatin and drugs for Alzheimer’s disease – with Bengt Winblad, professor, senior at Karolinska Institutet. (Swedish)
| |
|
June 11, 2021
|
| ACD440 – A Novel TRPV1 Antagonist for the Topical Treatment in Neuropathic Pain – Scientific presentation at the IASP conference on pain, June 2021
|
|
|
June 9, 2021
|
| Alzecure: CEO Martin Jönsson present at Redeye Growth Day
| |
|
June 7, 2021
|
| CEO presentation at the annual meeting (Swedish)
| |
|
May 20, 2021
|
| CEO Martin Jönsson after the company’s annual meeting
| |
|
May 17, 2021
|
| Update on Progress in the Painless Platform, May 11, 2021
|
|
|
May 11, 2021
|
| Company overview and goals by CEO Martin Jönsson, May 11, 2021
|
|
|
May 11, 2021
|
| Chronic Pain – a high unmet medical need by CMO Märta Segerdahl, May 11, 2021
|
|
|
May 11, 2021
|
| ACD 440 – A novel VR1 antagonist for neuropathic pain by CSO Johan Sandin, May 11, 2021
|
|
|
May 11, 2021
|
| TrkA- NAM – Project in osteoarthritis & other severe pain conditions by Head of Discovery & Research Pontus Forsell, May 11, 2021
|
|
|
May 11, 2021
|
| Alzecure: Interview with CEO Martin Jönsson and CSO Johan Sandin (video)
| |
|
April 20, 2021
|
| Alzecure: Interview with CEOMartin Jönsson (video). (Swedish)
| |
|
March 1, 2021
|
| Interview with Martin Jönsson CEO in Aktiespararna’s analysis guide
| |
|
February 8, 2021
|
| CEO Martin Jönsson presentation, Aktiedagen Lund
| |
|
January 27, 2021
|
| Interview with Johan Sandin (CSO) in Aktiespararna’s analysis guide
| |
|
January 22, 2021
|
| Improving Quality of Life for People with Neurodegenerative Diseases – Stockholm Researchers and Health Tech Companies
|
| |
January 14, 2021
|
